Restasis 0.05% (Cyclosporine Eye Drops) 0.05% / ml

Restasis 0.05% eye drops contain cyclosporine, a prescription medication used to increase tear production in patients with chronic dry eye disease. These preservative-free ophthalmic drops help manage symptoms like irritation and discomfort. Store at room temperature and protect from light.

Strength

0.05% / ml

Pack Size

30s

Storage

15-25°

Manufacturer / TM Owner

Allergan

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Restasis 0.05% eye drops are used to treat chronic dry eye disease by increasing natural tear production. They help relieve symptoms such as burning, stinging, and redness caused by reduced tear volume. This medication is often prescribed when other treatments have not provided sufficient relief.

Side Effects

Restasis 0.05% eye drops work gradually to improve tear film stability over time. Users may notice reduced eye irritation and a more comfortable sensation after consistent use. Results vary, and some individuals may experience temporary stinging or blurred vision immediately after application.

Precautions & Warnings

Handle eye drops with clean hands to avoid contamination. Do not touch the dropper tip or let it touch any surface, including the eye. Remove contact lenses before use and wait at least 15 minutes before reinserting them. Discard any remaining solution after opening to maintain sterility.

Avoid Interactions

Restasis 0.05% eye drops are generally well-tolerated and do not interact significantly with other medications. However, concurrent use of other eye drops should be spaced at least 5 minutes apart to prevent dilution. Avoid using with artificial tears unless directed by a healthcare provider.

Frequently Asked Questions

Restasis 0.05% is used to treat chronic dry eye disease by increasing tear production.

Effects may take several weeks of consistent use to become noticeable.

Remove contact lenses before applying Restasis and wait 15 minutes before reinserting them.

Restasis is designed for ongoing use under medical supervision to manage chronic dry eye.

Apply the missed dose as soon as you remember, but skip it if it's almost time for the next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.